この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Dr. Oksana S.に依頼
Israel
Scientist | HIV & COVID-19 | Phylogeographic Analysis of Population-Scale Datasets | Computational Epidemiology
プロフィール概要
専門分野
サービス
Writing
Medical Writing,
General Proofreading & Editing
Research
Meta-Research,
Feasibility Study,
Fact Checking,
Gap Analysis,
Scientific and Technical Research
Consulting
Healthcare Consulting,
Scientific and Technical Consulting,
Regulatory Consulting
Data & AI
Predictive Modeling,
Statistical Analysis,
Image Analysis,
Data Visualization,
Data Cleaning,
Data Processing
Product Development
Product Evaluation,
Concept Development,
Reverse Engineering
職務経験
Medical consultant
Le Sallay Academy
3月 2025 - 現在
Doctoral Scientist
Ariel University
11月 2024 - 現在 ![]()
Lectuter
Faculty of Liberal Arts in Montenegro
9月 2025 - 1月 2026
Researcher
Tel Aviv University
7月 2025 - 12月 2025 ![]()
Medical consultant
Humanitarian Action (MSF), Saint-Petersburg
2月 2022 - 1月 2023
MEDICAL DOCTOR/PUBLIC HEALTH/EPIDEMIOLOGIST
First Pavlov State Medical University of Saint-Petersburg
8月 2016 - 5月 2022
Invited Researcher
European University of Saint Petersburg
9月 2021 - 3月 2022
Doctoral Researcher
Influenza Research Institute
9月 2018 - 8月 2021
学歴
Masters of Science
ITMO University of Saint-Petersburg
9月 2021 - 8月 2023
Bioinformatics Researcher
Bioinformatics Institute of Saint-Petersburg
8月 2016 - 8月 2017
Medical Degree (MD)
First Pavlov State Medical University of Saint Petersburg, Russia
9月 2009 - 7月 2015
認定資格
-
Public Health Sciences
ITMO University of Saint Petersburg
8月 2023 - 現在
-
Cybersecurity Bootcamp
Thrive DX, Tel Aviv, Israel
5月 2023 - 現在
-
Bioinformatics
Bioinformatics Institute of Saint-Petersburg
5月 2017 - 現在
-
Infectious Diseases & Epidemiology
First Pavlov State Medical University of Saint-Petersburg, Russia
8月 2016 - 現在
-
General medicine
First Pavlov State Medical University of Saint-Petersburg, Russia
7月 2015 - 現在
出版物
PREPRINT
Oksana Stanevich (2024). Free Social Science: Definitions .
Oksana Stanevich, Anton Barchuk, Anna Bulina, Mikhail Cherkashin, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, Dmitriy Skougarevskiy, Artemiy Okhotin(2022). COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a population-based case-control study in St. Petersburg, Russia . Cold Spring Harbor Laboratory
Oksana Stanevich, Anton Barchuk, Mikhail Cherkashin, Anna Bulina, Natalia Berezina, Tatyana Rakova, Darya Kuplevatskaya, Dmitriy Skougarevskiy, Artemiy Okhotin(2021). Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Case-Control Study in St. Petersburg, Russia . Cold Spring Harbor Laboratory
Oksana Vladimirovna Stanevich, Daria S. Fomina, Igor G. Bakulin, Shamil I. Galeev, Evgeny A. Bakin, Vasilii A. Belash, Alexandr N. Kulikov, Alexandra A. Lebedeva, Dmitry A. Lioznov, Yury S. Polushin, et al. (2021). Ruxolitinib Versus Dexamethasone in Hospitalized Adults With COVID-19: Multicenter Matched Cohort Study .
JOURNAL ARTICLE
M. A. Saitgalina, Yulia V. Ostankova, Natalia A. Arsentieva, Zoya R. Korobova, Natalia E. Liubimova, Victor A. Kashchenko, Alexandr N. Kulikov, Dmitry E. Pevtsov, Oksana V. Stanevich, Ekaterina I. Chernykh, et al. (2023). Assessment of trec and krec levels in COVID-19 patients with varying disease severity . Russian Journal of Infection and Immunity.
Maria A. Saitgalina, Yu. V. Ostankova, N. A. Arsentieva, Z. R. Korobova, N. E. Liubimova, V. A. Kashchenko, A. N. Kulikov, D. E. Pevtsov, O. V. Stanevich, E. I. Chernykh, et al. (2023). Levels of TREC and KREC molecules significance determining in peripheral blood for predicting the outcome of COVID-19 disease in the acute period . Russian Journal of Immunology.
Oksana V. Stanevich, Evgeniia I. Alekseeva, Maria Sergeeva, Artem V. Fadeev, Kseniya S. Komissarova, Anna A. Ivanova, Tamara S. Simakova, Kirill A. Vasilyev, Anna-Polina Shurygina, Marina A. Stukova, et al.(2023). SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19 . Nature Communications. 14. (1). Springer Science and Business Media {LLC}
Stanevich, O.V., Alekseeva, E.I., Sergeeva, M., Fadeev, A.V., Komissarova, K.S., Ivanova, A.A., Simakova, T.S., Vasilyev, K.A., Shurygina, A.-P., Stukova, M.A., et al.(2023). SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19 . Nature Communications. 14. (1).
Oksana V. Stanevich, Evgeny A. Bakin, Aleksandra A. Korshunova, Alexandra Ya. Gudkova, Aleksey A. Afanasev, Irina V. Shlyk, Dmitry A. Lioznov, Yury S. Polushin, Alexandr N. Kulikov (2022). Informativeness estimation for the main clinical and laboratory parameters in patients with severe COVID-19 . Terapevticheskii arkhiv.
Korobova, Z.R., Arsentieva, N.A., Liubimova, N.E., Dedkov, V.G., Gladkikh, A.S., Sharova, A.A., Chernykh, E.I., Kashchenko, V.A., Ratnikov, V.A., Gorelov, V.P., et al.(2022). A Comparative Study of the Plasma Chemokine Profile in COVID-19 Patients Infected with Different SARS-CoV-2 Variants . International Journal of Molecular Sciences. 23. (16).
Kudryavtsev, I.V., Arsentieva, N.A., Batsunov, O.K., Korobova, Z.R., Khamitova, I.V., Isakov, D.V., Kuznetsova, R.N., Rubinstein, A.A., Stanevich, O.V., Lebedeva, A.A., et al.(2022). Alterations in B Cell and Follicular T-Helper Cell Subsets in Patients with Acute COVID-19 and COVID-19 Convalescents . Current Issues in Molecular Biology. 44. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 194-205.
Barchuk, A., Bulina, A., Cherkashin, M., Berezina, N., Rakova, T., Kuplevatskaya, D., Stanevich, O., Skougarevskiy, D., Okhotin, A.(2022). COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia . BMC Public Health. 22. (1).
Korobova, Z.R., Arsentieva, N.A., Liubimova, N.E., Batsunov, O.K., Dedkov, V.G., Gladkikh, A.S., Sharova, A.A., Adish, Z., Chernykh, E.I., Kaschenko, V.A., et al.(2022). Cytokine Profiling in Different SARS-CoV-2 Genetic Variants . International Journal of Molecular Sciences. 23. (22).
Kudryavtsev, I.V., Arsentieva, N.A., Korobova, Z.R., Isakov, D.V., Rubinstein, A.A., Batsunov, O.K., Khamitova, I.V., Kuznetsova, R.N., Savin, T.V., Akisheva, T.V., et al.(2022). Heterogenous CD8+ T Cell Maturation and ‘Polarization’ in Acute and Convalescent COVID-19 Patients . Viruses. 14. (9).
Korobova, Z.R., Zueva, E.V., Arsentieva, N.A., Batsunov, O.K., Liubimova, N.E., Khamitova, I.V., Kuznetsova, R.N., Rubinstein, A.A., Savin, T.V., Stanevich, O.V., et al.(2022). Changes in Anti-SARS-CoV-2 IgG Subclasses over Time and in Association with Disease Severity . Viruses. 14. (5).
Arsentieva, N.A., Liubimova, N.E., Batsunov, O.K., Korobova, Z.R., Kuznetsova, R.N., Rubinstein, A.A., Stanevich, O.V., Lebedeva, A.A., Vorobyov, E.A., Vorobyova, S.V., et al.(2022). PREDICTIVE VALUE OF SPECIFIC CYTOKINES FOR LETHAL COVID-19 OUTCOME,ПРОГНОЗНАЯ ЗНАЧИМОСТЬ СПЕЦИФИЧЕСКИХ ЦИТОКИНОВ В ОТНОШЕНИИ ЛЕТАЛЬНОГО ИСХОДА COVID-19 . Russian Journal of Infection and Immunity. 12. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 859-868.
Barchuk, A., Cherkashin, M., Bulina, A., Berezina, N., Rakova, T., Kuplevatskaya, D., Stanevich, O., Skougarevskiy, D., Okhotin, A.(2022). Vaccine effectiveness against referral to hospital after SARS-CoV-2 infection in St. Petersburg, Russia, during the Delta variant surge: a test-negative case-control study . BMC Medicine. 20. (1).
Stanevich, O.V., Bakin, E.A., Korshunova, A.A., Gudkova, A.Y.A., Afanasev, A.A., Shlyk, I.V., Lioznov, D.A., Polushin, Y.S., Kulikov, A.N.(2022). Informativeness estimation for the main clinical and laboratory parameters in patients with severe COVID-19,Информативность основных клинико-лабораторных показателей для пациентов с тяжелой формой COVID-19 . Terapevticheskii Arkhiv. 94. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1225-1233.
Evgeny A. Bakin and Oksana V. Stanevich and Mikhail P. Chmelevsky and Vasily A. Belash and Anastasia A. Belash and Galina A. Savateeva and Veronika A. Bokinova and Natalia A. Arsentieva and Ludmila F. Sayenko and Evgeny A. Korobenkov and Dmitry A. Lioznov and Areg A. Totolian and Yury S. Polushin and Alexander N. Kulikov(2021). A Novel Approach for COVID-19 Patient Condition Tracking: From Instant Prediction to Regular Monitoring . Frontiers in Medicine. 8. Frontiers Media {SA}
Evgeny A. Bakin, Oksana V. Stanevich, Daria M. Danilenko, Dmitry A. Lioznov, Alexander N. Kulikov(2021). Fast prototyping of a local fuzzy search system for decision support and retraining of hospital staff during pandemic . Health Information Science and Systems. 9. (1). Springer Science and Business Media {LLC}
O. V. Stanevich, D. S. Fomina, I. G. Bakulin, S. I. Galeev, E. A. Bakin, V. A. Belash, A. N. Kulikov, A. A. Lebedeva, D. A. Lioznov, Yu. S. Polushin, et al. (2021). Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study . BMC Infectious Diseases.
O.V. Goloshchapov, A.B. Chukhlovin, O.V. Stanevich, R.V. Klement’eva, A.A. Shcherbakov, A.N. Shvetsov, O.V. Paina, P.V. Kozhokar, M.V. Gorchakova, M.A. Suvorova, et al.(2021). FECAL MICROBIOTA TRANSPLANTATION IN CHILDREN: FIRST EXPERIENCE AND PROSPECTS FOR CLINICAL APPLICATION . Pediatria. Journal named after G.N. Speransky. 100. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 17--27. Pediatria, Ltd.
Goloshchapov, O.V., Bakin, E.A., Stanevich, O.V., Klementeva, R.V., Shcherbakov, A.A., Shvetsov, A.N., Paina, O.V., Kozhokar, P.V., Gorchakova, M.V., Babenko, E.V., et al.(2021). Clinical and immune effects of fecal microbiota transplantation in children with acute graft-versus-host disease . Cellular Therapy and Transplantation. 10. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 69-78.
Arsentieva, N.A., Liubimova, N.E., Batsunov, O.K., Korobova, Z.R., Stanevich, O.V., Lebedeva, A.A., Vorobyov, E.A., Vorobyova, S.V., Kulikov, A.N., Lioznov, D.A., et al.(2021). Plasma cytokines in patients with COVID-19 during acute phase of the disease and following complete recovery,ЦИТОКИНЫ В ПЛАЗМЕ КРОВИ БОЛЬНЫХ COVID-19 В ОСТРОЙ ФАЗЕ ЗАБОЛЕВАНИЯ И ФАЗЕ ПОЛНОГО ВЫЗДОРОВЛЕНИЯ . Medical Immunology (Russia). 23. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 311-326.
Kalmanson, L.M., Shlyk, I.V., Polushin, Y.U.S., Stanevich, O.V., Galkina, A.A.(2021). The Effect of Nosocomial Infection on the Severity and Outcome of the Disease in Patients with Severe and Extremely Severe COVID-19,Влияние нозокомиальной инфекции на тяжесть течения и исход заболевания у пациентов с COVID-19 тяжелого и крайне тяжелого течения . Messenger of Anesthesiology and Resuscitation. 18. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 15-21.
Goloshchapov, O.V., Chukhlovin, A.B., Stanevich, O.V., Klement’eva, R.V., Shcherbakov, A.A., Shvetsov, A.N., Paina, O.V., Kozhokar, P.V., Gorchakova, M.V., Suvorova, M.A., et al.(2021). FECAL MICROBIOTA TRANSPLANTATION IN CHILDREN: FIRST EXPERIENCE AND PROSPECTS FOR CLINICAL APPLICATION . Pediatriya - Zhurnal im G.N. Speranskogo. 100. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 17-27.
Stanevich, O.V., Fomina, D.S., Bakulin, I.G., Galeev, S.I., Bakin, E.A., Belash, V.A., Kulikov, A.N., Lebedeva, A.A., Lioznov, D.A., Polushin, Y.S., et al.(2021). Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: multicenter matched cohort study . BMC Infectious Diseases. 21. (1).
Bakin, E.A., Stanevich, O.V., Danilenko, D.M., Lioznov, D.A., Kulikov, A.N.(2021). Fast prototyping of a local fuzzy search system for decision support and retraining of hospital staff during pandemic . Health Information Science and Systems. 9. (1).
Bakin, E.A., Stanevich, O.V., Chmelevsky, M.P., Belash, V.A., Belash, A.A., Savateeva, G.A., Bokinova, V.A., Arsentieva, N.A., Sayenko, L.F., Korobenkov, E.A., et al.(2021). A Novel Approach for COVID-19 Patient Condition Tracking: From Instant Prediction to Regular Monitoring . Frontiers in Medicine. 8.
O. V. Goloshchapov, A. B. Chukhlovin, E. A. Bakin, O. V. Stanevich, R. V. Klementeva, A. A. Shcherbakov, A. N. Shvetsov, M. A. Suvorova, S. N. Bondarenko, M. A. Kucher, et al.(2020). Fecal microbiota transplantation for graft-versus-host disease in children and adults: methods, clinical effects, safety . Terapevticheskii arkhiv. 92. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 43--54. Consilium Medicum
Goloshchapov, O.V., Chukhlovin, A.B., Bakin, E.A., Stanevich, O.V., Klementeva, R.V., Shcherbakov, A.A., Shvetsov, A.N., Suvorova, M.A., Bondarenko, S.N., Kucher, M.A., et al.(2020). Fecal microbiota transplantation for graft-versus-host disease in children and adults: Methods, clinical effects, safety,Трансплантация фекальной микробиоты при реакции «трансплантат против хозяина» у детей и взрослых: методы, клинические эффекты, безопасность . Terapevticheskii Arkhiv. 92. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 43-54.
Goloshchapov, O.V., Bakin, E.A., Kucher, M.A., Stanevich, O.V., Suvorova, M.A., Gostev, V.V., Glotov, O.S., Eismont, Y.A., Polev, D.E., Lobenskaya, A.Y., et al.(2020). Bacteroides fragilis is a potential marker of effective microbiota transplantation in acute graft-versus-host disease treatment . Cellular Therapy and Transplantation. 9. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 47-59.
Malinina, D.A., Shlyk, I.V., Polushin, Y.S., Afanasiev, A.A., Stanevich, O.V., Bakin, E.A.(2020). The informative value of proadrenomedullin in patients with severe COVID-19 . Messenger of Anesthesiology and Resuscitation. 17. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 31-38.
Ayzsilnieks, O., Popova, M., Volkova, A., Pinegina, O., Ignatyeva, S., Ekushev, K., Slesarchuk, O., Vladovskaya, M., Zubarovskaya, L., Klimko, N., et al.(2016). Invasive fungal diseases in adolescents and young adults after allogeneic hematopoietic stem cell transplantation . Cellular Therapy and Transplantation. 5. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 71-74.
OTHER
Barchuk, A., Bulina, A., Cherkashin, M., Berezina, N., Rakova, T., Kuplevatskaya, D., Stanevich, O., Skougarevskiy, D., Okhotin, A.(2022). COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a population-based case-control study in St. Petersburg, Russia . medRxiv.
O.V. Stanevich, D.S. Fomina, I.G. Bakulin, Sh. I. Galeev, E.A. Bakin, V.A. Belash, A.N. Kulikov, A.A. Lebedeva, D.A. Lioznov, Yu S. Polushin, et al.(2021). Ruxolitinib versus Dexamethasone in Hospitalized Adults with Covid-19: multicenter matched-controlled study . Cold Spring Harbor Laboratory
Evgeny A. Bakin, Oksana V. Stanevich, Vassily A. Belash, Anastasia A. Belash, Galina A. Savateeveva, Veronika A. Bokinova, Natalia A. Arsentieva, Ludmila F. Sayenko, Evgeny A. Korobenkov, Dmitry A. Lioznov, et al.(2021). A precise score for the regular monitoring of COVID-19 patients condition validated within the first two waves of the pandemic . Cold Spring Harbor Laboratory
Stanevich, O.V., Alekseeva, E.I., Sergeeva, M., Fadeev, A.V., Komissarova, K.S., Ivanova, A.A., Simakova, T.S., Vasilyev, K.A., Shurygina, A.-P., Stukova, M.A., et al.(2021). SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19 . ResearchSquare.
Stanevich, O.V., Fomina, D.S., Bakulin, I.G., Galeev, Sh.I., Bakin, E.A., Belash, V.A., Kulikov, A.N., Lebedeva, A.A., Lioznov, D.A., Polushin, Yu.S., et al.(2021). Ruxolitinib versus dexamethasone in hospitalized adults with COVID-19: Multicenter matched-controlled study . medRxiv.
Barchuk, A., Cherkashin, M., Bulina, A., Berezina, N., Rakova, T., Kuplevatskaya, D., Stanevich, O., Skougarevskiy, D., Okhotin, A.(2021). Vaccine Effectiveness against Referral to Hospital and Severe Lung Injury Associated with COVID-19: A Case-Control Study in St. Petersburg, Russia . medRxiv.
CONFERENCE PAPER
Gazizova, A., Andrey, Z., Myrov, V., Vinogradova, A., Cheblokov, A., Bakin, E., Stanevich, O.(2018). Open source tool for VH-replacement products discovery and analysis . Conference of Open Innovation Association, FRUCT. 2018-May. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 48-54.